Canonical page: https://sequoia-research.com/writing/dst-brokers-2026-why-offering-access-matters-when-selecting-a-broker
Author: Sequoia Research
Published: 2026-10-18T01:28:22.829Z
Updated: 2026-10-18T01:28:22.829Z

# DST Brokers (2026): Why Offering Access Matters When Selecting a Broker

## What Is This Article About?

This article examines how a DST broker's product list can shape the investments an investor sees. It compares public access limits disclosed by Capulent, WealthForge, and Realized, using sources read in October 2026. These sources did not provide complete current approved lists or confirm access for a specific investor. Original examples show how to separate firm approval, a representative's permissions, open capacity, and the investor's needs. The aim is to help readers assess a broker's reach without turning a product count into a quality ranking.

## Table of Contents

- [Why DST Offering Access Affects Broker Selection](#why-dst-offering-access-affects-broker-selection)
- [What Three Firms Publicly Disclose About Access](#what-three-firms-publicly-disclose-about-access)
- [Define What an Approved Product List Covers](#define-what-an-approved-product-list-covers)
- [Check the Representative's Access Separately](#check-the-representatives-access-separately)
- [Follow an Offering Through Four Access Checks](#follow-an-offering-through-four-access-checks)
- [Keep Unknown Access Separate From a Rejection](#keep-unknown-access-separate-from-a-rejection)
- [Compare What a Second Broker Adds](#compare-what-a-second-broker-adds)
- [Ask About Capacity for the Exact Investment](#ask-about-capacity-for-the-exact-investment)
- [Track Approval Changes and Paused Offerings](#track-approval-changes-and-paused-offerings)
- [Understand the Limits of a Restricted Menu](#understand-the-limits-of-a-restricted-menu)
- [Request a Useful Written Access Response](#request-a-useful-written-access-response)
- [Judge the Explanation Behind the Shortlist](#judge-the-explanation-behind-the-shortlist)
- [Frequently Asked Questions](#frequently-asked-questions)
- [About Sequoia Research](#about-sequoia-research)
- [Sources](#sources)

## Why DST Offering Access Affects Broker Selection

A broker's reach matters because an investor can only compare the choices brought into the review. A Delaware statutory trust, or DST, may look appealing on a sponsor's website yet fall outside a broker's product range. A product may also be on the firm's list while being unavailable through the person handling the investor's request. Asking about access early helps reveal those limits before a shortlist begins to feel final.

The word “access” can hide several different claims. A firm might have a relationship with a sponsor. It might have approved one of that sponsor's offerings. A representative might be allowed to present that offering. The issuer might still accept new subscriptions, which are requests to buy an interest. Each statement answers a different question.

Start with the choice the broker can actually help evaluate. Then work backward to the evidence behind it. Which legal offering is involved? Who approved it? What does that approval allow? Which facts remain subject to a later response? A useful explanation follows this chain without treating one link as proof of the rest.

This article uses “approved list” to mean a firm's own list of products that have passed its stated review for a stated purpose. The label alone says little about that purpose. Ask whether it permits discussion, recommendations, new sales, or only service for existing owners. Those are questions to resolve in the firm's records; they are not assumed standard labels across the industry.

An access review also needs an investor's real constraints. A larger menu may add choices with hold periods, risks, or minimum amounts the investor cannot accept. A smaller menu may leave a meaningful gap. Find out which is true. The size of the list alone cannot settle that question.

For example, someone may have a small amount left to place. They may need exact minimums and rules for a partial purchase. Another person may care more about property type. Or they may want less exposure to a manager they already use. The same catalog can be useful in different ways to those two people. That usefulness cannot be read from the catalog's total count.

Keep the access decision distinct from the investment decision. Learning that a broker can offer a product gives the investor a path to review it. It does not settle whether the investment, its costs, its risks, or the proposed amount make sense. A product can pass every access check and still be declined after financial review.

## What Three Firms Publicly Disclose About Access

The following comparison covers selected public disclosures read on October 17, 2026. A customer relationship summary, called Form CRS, describes broad services and conflicts. These records do not provide a complete, live DST list. They do not establish what any reader could buy. Dates below identify the documents, not the date of a newly confirmed selling arrangement.

| Firm and public record | Disclosed limit relevant to access | Question left for the proposed relationship |
|---|---|---|
| Capulent, January 1, 2026 Form CRS | Named product types and issuers with selling agreements limit its menu | Which exact offerings fall within those agreements today? |
| WealthForge, April 15, 2025 Form CRS | Some representatives may be limited to securities of an outside employer or an associated entity | Does that limit apply to the person proposed for this file? |
| Realized, June 30, 2025 Form CRS | Its real estate focus and limited platform define the range of choices | Which products can this service, account, and representative present? |

Capulent describes limited brokerage services involving private placements and other named product types. Its summary says the menu is limited to those types and issuers with selling agreements. This is evidence of a commercial and product boundary. It does not disclose the number of currently open DST offerings or prove that a named issuer has an active agreement for every product. [Capulent Form CRS](https://files.brokercheck.finra.org/crs_155155.pdf)

WealthForge describes limited brokerage services. Its conflict disclosure says some representatives may sell, and in some cases may sell only, securities issued by their outside employer or an associated entity. The qualification matters: the source does not apply that restriction to every representative. An investor needs an answer tied to the proposed person. [WealthForge Form CRS](https://files.brokercheck.finra.org/crs_152550.pdf)

Realized describes services focused on a subset of real estate investments, including DSTs. Its summary says the platform has a limited selection and that other firms may offer a wider range. It also distinguishes brokerage from advisory services. An investor should identify which relationship is proposed before treating a platform description as their own service terms. [Realized Form CRS](https://www.realized1031.com/hubfs/common-files/disclosures/FormCRS.pdf)

Realized's public broker-dealer partner page adds a stated review process. It describes review of sponsors, properties, and structures, followed by a committee. The page says deals must pass the internal review to enter custom portfolios. This is the firm's account of its process; this article did not inspect committee files, test internal controls, or obtain current approval decisions. [Realized broker-dealer partner page](https://www.realized1031.com/partners/broker-dealers)

The comparison supports three different follow-up paths: ask about agreements, the person's limits, and the product review process. It cannot support a breadth ranking. A firm that explains one limit in greater detail has not thereby shown that its menu is smaller. Likewise, silence on a detail in a short public record does not establish that no limit exists.

## Define What an Approved Product List Covers

Ask for the date, owner, and purpose of any list used to build the shortlist. “Our firm approved it” is hard to assess without the exact issuer and offering version. A sponsor may run several programs. Approval of one does not, by itself, establish the status of another.

The issuer is the legal entity selling the investment interest. The sponsor organizes or manages the program through the roles set out in its documents. A property address can help identify an asset, but it cannot replace the issuer's name. Several assets may sit in one offering, and a new offering may use a familiar property or sponsor name.

Use one record per exact offering being considered. Record the legal name, the class or purchase route where relevant, and the document date. If two entries have similar names, ask whether they are separate investments, separate classes, or duplicate descriptions. Preserve that answer with the list.

Next, ask what the firm's review covered. Was the decision limited to a specific set of documents? Were there conditions before a new sale could proceed? Is a later amendment still being reviewed? An investor does not need access to every internal note to ask whether an unresolved condition affects the proposed purchase.

A firm may decline to share internal review material. Record that access limit without treating it as proof of a deficient review. The practical question is whether the broker can still explain the product, the relevant decision, and the remaining steps using material available to the investor. If the answer depends on an unseen term, identify that term rather than replacing it with confidence in a logo.

## Check the Representative's Access Separately

The firm name on a website and the person serving the client are different levels of the review. Start by confirming the person's role and the entity through which the proposed service will be provided. Then ask whether that person can present the entire relevant firm menu or only part of it.

A response such as “our firm works with many sponsors” leaves this unresolved. A more useful answer names the choices the person can offer. It explains limits that matter to the request. The answer should also distinguish the current relationship from one the person might arrange later.

Suppose an investor changes representatives within a firm. It would be easy to assume that the same shortlist carries over without review. Ask the new person to confirm what they can offer and which earlier decisions remain usable. The purpose is to check the handoff. Changing people may or may not change access.

Professional judgment also matters after firm approval. The Financial Industry Regulatory Authority, or FINRA, says a firm's investigation does not remove an individual broker's own obligations for a recommendation. Its 2023 notice discusses the need to understand relevant private-placement risks, rewards, and costs. A firm's approved label therefore does not answer every question a client should ask the person making the recommendation. [FINRA Regulatory Notice 23-08](https://www.finra.org/rules-guidance/notices/23-08)

Ask the representative to explain one material risk from the current documents and how it bears on the proposed amount. A useful answer connects the evidence to the investor's needs. A recital of the approval process leaves that link unexplained. This is a qualitative interview step, not a licensing exam or a score that proves competence.

## Follow an Offering Through Four Access Checks

Consider an invented example involving Nina and two fictional firms, Larch Brokerage and Maple Brokerage. None of the names, offerings, counts, or responses in the examples below describes the three actual firms discussed above. The examples illustrate record handling, not a recommendation for a real investor.

Nina receives a dated list of eight offerings from Larch. The list uses unique issuer identifiers, A through H. She asks four questions about each one. Is it firm-approved? Can her proposed representative offer it? Is a new purchase reported open? Does it pass her initial research constraints?

Nina's initial research constraints cover only the amount and a chosen property-type limit. Passing them is not a best-interest finding or a completed investment review. In this example, each reached check has a known answer at the stated review time. Later checks remain untested where an earlier step fails.

| Offering | On firm list | Proposed person can offer | New purchase reported open | Passes Nina's initial constraints |
|---|---|---|---|---|
| A | Yes | Yes | Yes | Yes |
| B | Yes | Yes | Yes | No |
| C | Yes | Yes | No | Not reached |
| D | Yes | Yes | Yes | No |
| E | Yes | Yes | Yes | Yes |
| F | Yes | Yes | No | Not reached |
| G | Yes | No | Not reached | Not reached |
| H | Yes | No | Not reached | Not reached |

Eight offerings are on the firm list. Six can be offered by the proposed person. Four of those six are reported open. Two of those four pass Nina's initial constraints. The resulting path is 8, then 6, then 4, then 2. The table shows each change rather than presenting the final two as the firm's entire range.

Two divided by eight is 25%. Here, that number means only that a quarter of the starting rows reached the final research step. It is not a success rate or a measure of broker quality. It does not show the chance of closing. Different constraints could produce a different result from the same eight rows.

The phrase “not reached” also matters. G and H have not been tested for capacity in this workflow because the proposed person cannot offer them. Their capacity remains outside the completed review. Calling them closed would invent a fact. Similarly, C and F were not tested against Nina's constraints after the capacity check failed.

Nina can now ask targeted questions. If A drops out, does E still make sense on its own? Could a different authorized person discuss G without changing other service terms? Would learning more about B change the reason it failed the first screen? Each answer must be obtained; the table does not supply it.

Keep the original table when a reply changes. If A later closes, one of the two current candidates remains. The revised candidate count is one, while the original eight-row list remains part of the history. Replacing eight with one everywhere would erase useful context about how the choice narrowed.

The table can also expose an unsuitable starting point. If neither A nor E passes a later risk review, the final result can be no purchase from this list. That result should stay available even after time has been spent collecting the files. Research effort is not a reason to relax an important constraint.

## Keep Unknown Access Separate From a Rejection

Real responses are often less tidy than the example. A missing answer should remain missing. Do not turn “not yet confirmed” into either available or unavailable just to complete a spreadsheet.

In a separate fictional batch, Nina asks about six exact offerings. She receives three affirmative replies, one negative reply, and no usable answer for two. Four of six have a resolved status, or about 66.7%. Three of the four resolved replies are affirmative, or 75%. Three of the whole six-row batch are affirmative, or 50%.

All three percentages are mathematically correct. They describe different things. Reporting only 75% without its denominator would make the response look more complete than it is. Nina should keep the simple counts beside any percentage: three yes, one no, two unknown.

If both unknowns become yes, five of six will have affirmative replies. If both become no, three of six will. That range describes missing access information. It does not estimate which answer is likely, and it says nothing about the quality of the products.

A refusal and an unresolved inquiry also need different notes. “We cannot offer this issuer” may close the question for that relationship. “We are waiting for a firm decision” leaves a condition open. Ask who owns the next answer and what event should prompt an update. Avoid putting an invented deadline beside it.

Where evidence conflicts, retain both versions. A dated email that says an offering is paused should not disappear because an older catalog still says open. Request a response about the conflict. Until it arrives, label the status as conflicting rather than deciding that the newer-looking website must be right.

## Compare What a Second Broker Adds

A second broker may add useful choices. It may also offer a different service that the investor needs. Adding another catalog does not automatically widen the set by the number of rows it contains.

Continue the fictional case. Larch's full list is A through H. Maple's list is D, E, F, G, H, I, and J. Larch has eight unique offerings and Maple has seven. Five appear in both lists. Together they cover ten unique offerings: eight plus seven minus five. Maple adds I and J to Larch's full list, not seven new investments.

The result changes when Nina compares only her initial research candidates. Larch's candidates are A and E. Suppose Maple's candidates are E, I, and J after separate checks through its proposed person. Their combined candidate set is A, E, I, and J: four unique offerings. Maple adds two at this stage as well, but that result comes from a different comparison.

Keep each firm's answer in its own row. Do not borrow its approval or capacity answer to fill the other firm's row. The same offering identity can appear on both lists while the access route differs. Preserve separate evidence for Larch and Maple. Use a shared identifier only to avoid counting the investment twice.

Also ask what the added choices contribute. Suppose I and J share the same main tenant as A. Nina may have more legal offerings to review without gaining the tenant variety she hoped to obtain. The correct next step is to examine the overlap from the property records. Four offering names do not prove four independent sources of cash flow.

The added service may matter even when the menus overlap. A second firm might propose a different scope of advice or support, with different costs. Compare those written terms on their own. A count of extra offerings cannot measure the value of ongoing help, and access alone does not establish that such help is included.

## Ask About Capacity for the Exact Investment

An offering can remain on a firm's approved list after the space available for new investors changes. Ask about the exact amount, purchase route, and response time needed for the proposed transaction. A general statement that a program is open may not answer whether it can accept the amount being discussed.

Use a separate invented example. Nina wants to consider a $180,000 allocation. An issuer response reports $120,000 of remaining space, subject to its stated conditions. That leaves a $60,000 gap if she tries to place the full amount in that offering. An active selling agreement does not fill that gap.

She might explore a smaller allocation if the investment and transaction rules permit it. That is a new proposal to assess. It should not silently replace the $180,000 plan. The review would need to cover the remaining money, any revised costs, and the reason the split fits the broader plan.

Save what the capacity response actually says. Does it describe an estimate, a temporary hold, an accepted subscription, or a completed purchase? Ask which conditions remain and who can confirm their completion. Do not apply a generic status ladder as if every firm's terms have the same legal effect.

Avoid placing a value on an unconfirmed exception. A requested lower minimum or larger allocation is still a request until the relevant party gives an applicable response. Even then, the access decision remains separate from the investor's review of the investment itself.

## Track Approval Changes and Paused Offerings

A broker comparison should explain how access changes will reach the investor. Ask who will notify the investor when a new fact affects a product on the shortlist. The answer should describe the proposed service, rather than imply that a public website provides personal monitoring.

For a fictional sequence, suppose offering E is approved for new sales on October 1. On October 8, the firm pauses new submissions while reviewing an amendment. On October 12, it permits submissions again for the amended version. These dates illustrate a record; they do not describe any actual firm's actions.

A reply dated October 6 belongs to the first state. It cannot establish access during the October 8 pause. The October 12 decision should identify which version it covers and what remains required. It should not make the pause disappear from the history.

Suppose Nina has already reviewed the earlier version. Ask which facts changed and which parts of her review need another look. A changed debt term may affect cash available for distributions. A changed minimum may affect the amount she can place. A corrected address may affect document matching. Those changes require different follow-up work.

The record should separate a correction from a new decision. If the original list misspelled a name but referred to the same legal issuer, note the correction and its evidence. If the issuer or class changed, create a separate offering record. Reusing the old approval against a new identity would make the history unreliable.

Ask about the process for reviewing an offering outside the current list. A firm may explain what it needs and whether it will consider a request. Avoid treating a possible future review as present access. An estimated review period also does not promise a favorable decision or an available allocation when the review ends.

The investor's own needs can change during that process. Available cash may fall. The investor may need easier access to money. Revisit those needs with the broker before keeping the old candidate set. A careful access record is useful only while its assumptions still describe the proposed transaction.

## Understand the Limits of a Restricted Menu

A restricted menu is a fact to understand, not an automatic verdict about a firm. The important question is whether its available choices and services can support the investor's needs. There may be no suitable choice on a particular list.

The U.S. Securities and Exchange Commission, or SEC, addresses this issue in a 2023 staff bulletin. It says a limited menu cannot justify a recommendation that fails the investor's best-interest standard. The staff also explains that the best of the available choices may still be inappropriate for that investor. The bulletin is a staff statement, not a new rule. This does not mean a broker must review the whole market. The bulletin notes that Regulation Best Interest does not require review of alternatives outside the firm. [SEC staff bulletin on care obligations, questions 11–13 and footnote 56](https://www.sec.gov/about/divisions-offices/division-trading-markets/broker-dealers/staff-bulletin-standards-conduct-broker-dealers-investment-advisers-care-obligations)

For a reader, this supports a direct question: what happens if none of the offerings on this list works for me? A useful discussion leaves room for that outcome. The answer should not rely on the time already spent or the desire to finish a transaction.

A comparison with another firm can still be an investor's research choice. It should start with the specific gap: a product type, a minimum, an advice need, or another stated constraint. Without that focus, a second search may just produce more duplicates and a larger pile of files.

## Request a Useful Written Access Response

A written response works best when it asks for a small number of exact facts. State the proposed relationship and the offerings under review. Include the amount and relevant account or buyer details through an appropriate private channel. Do not place sensitive personal records in a broad request sent to several firms.

Ask the broker to distinguish the firm list from the representative's permitted range. For each exact offering, request the present status, the source date, and any condition that affects a new purchase. Where the answer is unknown, ask what is missing. A short, precise answer is easier to maintain than a long sales presentation.

Request the reason for each exclusion that matters to the shortlist. Useful categories might include outside the firm's range, not permitted for the proposed person, closed to new purchases, amount too small, or inconsistent with a stated investor constraint. These are suggested record labels. The broker should use language that accurately describes the actual decision.

Keep sensitive internal details separate from the practical answer. A firm may not share a committee memo, but it can be asked whether the product is approved for the proposed use and whether conditions remain. If it cannot provide an answer, record the gap rather than assuming either approval or rejection.

Give the response a clear review point. For example, ask for an update if an offering is paused, a document changes, or the proposed amount changes. Agree who will communicate the change. Do not assume an early access reply creates an ongoing service duty beyond the terms of the relationship.

Finally, preserve the original response alongside later updates. A reader should be able to see why an offering entered the shortlist, why it left, and which evidence supported each step. That record is far more useful than a single “available” flag with no date or explanation.

## Judge the Explanation Behind the Shortlist

The final shortlist should show a reason for each surviving choice. Ask the broker to connect its main benefits, risks, costs, and limitations to the investor's stated needs. Firm approval explains why a product could enter the discussion. The explanation of the recommendation must go further.

Review exclusions with the same care. Some may reflect a firm boundary; others may reflect an investment concern. Mixing those reasons can mislead a reader into thinking a product failed a risk review when it was never considered. Use the narrowest description supported by the response.

Listen for an explanation of tradeoffs. An offering with a lower minimum may solve an amount problem while increasing exposure to a sector the investor already owns. A wider menu may add options but require more review time. A quicker response may leave important information unresolved. None of these facts should be collapsed into a single access score.

A useful broker comparison describes the proposed service clearly. It shows which choices that service can support. It identifies what remains uncertain and what would change the shortlist. That makes the next conversation specific: obtain the missing evidence, revisit a constraint, review another route, or decide that no purchase from this menu should proceed.

## Frequently Asked Questions

### Does a Broker With More DST Offerings Always Provide Better Access?

A larger starting list may create more options, but the relevant count depends on the proposed person, current offering status, and investor constraints. Compare the exact offerings that reach the research stage for the same request. Then assess their financial merits and the service provided. A count cannot establish the quality of either the investments or the broker's advice.

### Does Firm Approval Mean the Offering Is Recommended for Me?

No. Firm approval and a recommendation for a particular investor are separate decisions. Ask what the firm's approval covers and how the broker evaluated the offering against your needs. A product might be permitted for discussion yet fail a later review for your amount, risks, or liquidity needs. Keep that distinction visible in the shortlist.

### Can Two People at the Same Firm Have Different Offering Access?

The public WealthForge disclosure discussed above gives a conditional example of person-level limits. Do not assume that every firm or representative uses the same arrangement. Ask about the exact person and role proposed for your file. If that person changes, request a fresh confirmation of the access and service terms that matter to your review.

### How Should I Compare Two Brokers With Overlapping Lists?

Match exact offering identities, then keep separate access evidence for each broker. Count shared offerings once when describing the combined investment set. Preserve separate rows when describing the service route. An offering appearing twice may provide two ways to discuss the same investment; it does not necessarily provide two different property exposures or two usable allocations.

### What Should I Do With an Offering Marked Under Review?

Ask what review remains, who owns the answer, and whether any present activity is permitted. Keep it outside a confirmed-access count until the applicable answer arrives. You may still research it if appropriate, but do not build a plan that depends on a favorable decision. Save the eventual response with its date and any stated conditions.

### Does an Open Offering Guarantee Space for My Amount?

No. Request a response tied to the exact amount and purchase route. Find out whether the response is an estimate, a conditional hold, or another defined status. A gap in capacity may call for a new plan. That plan needs its own review. The firm relationship and the product's open status do not settle those transaction details.

### Must a Broker Offer Every Investment in the Market?

No. A firm can have a defined product range. The SEC staff discussion cited above explains both the limits of a restricted menu and the need for an appropriate recommendation. An investor can ask what the broker cannot offer and decide whether more research is needed. That question should not be presented as a universal duty to review every outside product.

### What Is the Most Useful Document to Request First?

Request a dated response showing the exact offerings the proposed person can discuss for the stated relationship, plus known limits and unresolved questions. A public catalog is a useful starting reference, but it may omit those details. Pair the response with the current offering documents and written service terms before treating the shortlist as ready for an investment decision.

## About Sequoia Research

Sequoia Research, LLC provides independent research on DSTs and other real estate investment offerings. This educational library helps readers examine sources, compare claims, and prepare focused questions. The examples in this article do not recommend an investment or a broker for a particular reader.

## Sources

- [Capulent Form CRS](https://files.brokercheck.finra.org/crs_155155.pdf), January 1, 2026; page 1. Read October 17, 2026.
- [WealthForge Form CRS](https://files.brokercheck.finra.org/crs_152550.pdf), April 15, 2025; pages 1–2. Read October 17, 2026.
- [Realized Form CRS](https://www.realized1031.com/hubfs/common-files/disclosures/FormCRS.pdf), June 30, 2025; page 1. Read October 17, 2026.
- [Realized broker-dealer partner page](https://www.realized1031.com/partners/broker-dealers), undated public page. Read October 17, 2026.
- [FINRA Regulatory Notice 23-08](https://www.finra.org/rules-guidance/notices/23-08), May 9, 2023. Read October 17, 2026.
- [SEC staff bulletin on care obligations](https://www.sec.gov/about/divisions-offices/division-trading-markets/broker-dealers/staff-bulletin-standards-conduct-broker-dealers-investment-advisers-care-obligations), page displays April 30, 2023; questions 11–13, footnotes 1 and 56. Read October 17, 2026.


## Related Reading and Tools

- [1031 Exchange DST Brokers: What They Do During the Exchange Process](https://sequoia-research.com/writing/1031-exchange-dst-brokers-what-they-do-during-the-exchange-process)
- [Best DST Brokers (2026): How to Compare Service, Research, and Offering Access](https://sequoia-research.com/writing/best-dst-brokers-2026-how-to-compare-service-research-and-offering-access)
- [Best DST 1031 Exchange Companies (2026): What a Meaningful Comparison Should Include](https://sequoia-research.com/writing/best-dst-1031-exchange-companies-2026-what-a-meaningful-comparison-should-include)